Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Intelsius Celebrates 15 Years of Protecting Life’s Most Precious Cargo™

Published: Monday, January 28, 2013
Last Updated: Sunday, January 27, 2013
Bookmark and Share
Company announces launch of 15th Anniversary Celebration year.

Intelsius has announced the launch of its 15th Anniversary Celebration year.

“We are delighted to announce this milestone and intend to make it our most successful year ever,” said founder David Walsh, chief executive officer of Intelsius.

Walsh continued, “The answer to one problem created a new company that began making temperature controlled, regulatory compliant packaging 15 years ago and continues to create innovative solutions today.”

Intelsius was incorporated as DGP Group in 1998, when the company developed a unique packaging solution designed for the transportation of samples suspected of containing the BSE (Bovine Spongiform Encephalitis, or “Mad Cow Disease”) prion.

Within one year DGP Group commercialized the first UN-certified TSE/BSE sample shipper in the world.

The company, rebranded as Intelsius in 2010, has grown from three partners and expanded with offices and manufacturing facilities throughout the world including Europe, North America and Asia.

Intelsius now serves a wide range of organizations, including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries, to major laboratories.

Intelsius temperature-controlled packaging systems (-70ºC, -20ºC, 2-8ºC and 15-25 ºC) meet or exceed WHO, ISTA, IATA perishable goods and USP1079 standards.

In addition, where applicable, they comply with UN dangerous goods regulatory performance requirements.

Intelsius, at the cutting edge of temperature control technology, maintains an ISTA-certified laboratory and has hundreds of innovative solutions to its credit.

All Intelsius products are supported by proprietary temperature and excursion risk assessment software; ATMOS.

“Intelsius will continue to push the design envelope, developing solutions and technological services unavailable elsewhere in the temperature-controlled packaging industry,” said Walsh.

Walsh continued, “Patient safety has always been at the forefront of our minds, these last 15 years. This is a great opportunity to renew our commitment to listening to our clients, being responsive to their needs, and ultimately striving to anticipate their needs before they arise.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!